Tuesday, March 09, 2021 3:48:35 PM
A (soon to be released) Canaccord Genuity report?
A possible agreement from the FDA for the Company to file for an EUA? (“the Company aims to approach the FDA to obtain agreement on filing an Emergency Use Authorization (“EUA”) for Bucillamine…”)
An expansion of the clinical sites from 14 to…?
Any other reasonable thoughts?
Also, how good does Michael Frank’s recently bought shares look now? And, if today’s action is indicative of pending (good) news from the Company then could Michael Frank’s open market purchase be perceived as buying on insider knowledge?
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM
ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM